Normativa nazionale / Area Kite 4 dicembre 2023 Presentato in Senato il nuovo ‘Termometro Parlamentare degli ATMP’
Prodotti GS / Area HIV, Area COVID-19 9 ottobre 2023 Gilead to Present Latest Innovative Virology Data on Current and Potentially Transformative Therapies Across HIV and COVID-19 at IDWeek 2023
Prodotti competitors / Area Oncology, Area Kite, Area Onco-Ema 25 settembre 2023 Europe: Oncology CHMP Minutes for June 2023
Prodotti competitors / Area Onco-Ema 18 settembre 2023 CHMP Positive Opinion for quizartinib (Vanflyta) in newly diagnosed acute myeloid leukaemia (AML)
Normativa europea 14 luglio 2023 Virology Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) meeting on 24-26 April 2023 released on the 06th of July 2023.
Prodotti competitors / Area COVID-19 28 giugno 2023 COVID-19: Merck Withdraws EMA Application for LAGEVRIO
Prodotti competitors / Area Onco-Ema 19 giugno 2023 FDA grants accelerated approval to glofitamab-gxbm for selected relapsed or refractory large B-cell lymphomas
Prodotti GS 26 maggio 2023 Positive CHMP opinion to extend the use of Veklury® (remdesivir) to treat COVID-19 in people with severe renal impairment
Prodotti competitors / Area Kite, Area Onco-Ema 5 maggio 2023 Opinione positiva del CHMP per Columvi (glofitamab) all'autorizzazione all'immissione in commercio condizionata per il trattamento del linfoma diffuso a grandi cellule B
Prodotti competitors / Area COVID-19 5 maggio 2023 Veru announced agreement with FDA on a confirmatory Ph3 clinical trial for sabizabulin for the treatment of hospitalized adult patients with moderate-to-severe SARS-CoV-2 infection
